Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 2, 2009, Pages 108-113

  Scandellari, Raffaella ^a   Allemand, Emanuele ^a   Vettore, Silvia ^a   Plebani, Mario ^b   Randi, Maria Luigia ^a   Fabris, Fabrizio ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c Department of Medical and Surgical Sciences ^*  (Italy)

Author keywords

Eradication therapy; Helicobacter pylori; Idiopathic thrombocytopenic purpura; Platelet response

Indexed keywords

AMOXICILLIN; AUTOANTIBODY; AZATHIOPRINE; CAGA PROTEIN; CLARITHROMYCIN; DANAZOL; IMMUNOGLOBULIN G ANTIBODY; METRONIDAZOLE; OMEPRAZOLE; PENICILLIN G; PREDNISONE; STEROID; THROMBOCYTE ANTIBODY;

ADULT; AGED; ALLERGIC REACTION; ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERADICATION THERAPY; FECES ANALYSIS; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; THROMBOCYTE COUNT; TREATMENT RESPONSE;

ADULT; AGED; ANTIBODIES, BACTERIAL; AUTOANTIBODIES; BLOOD PLATELETS; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES;

EID: 62349120718     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32832315d8     Document Type: Article

References (41)

1. McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol 2000; 37:239-248.
2. Fabris F, Scandellari R, Randi ML, Carraro G, Luzzatto G, Girolami A. Attempt to improve the diagnosis of immune thrombocytopenia by combined use of two different platelet autoantibodies assays (PAIgG and MACE). Haematologica 2002; 87:1046-1052.
3. Fujimura K. Helicobacter pylori infection and idiopathic thrombocytopenic purpura. Int J Hematol 2005; 81:113-118.
4. Ko GH, Park HB, Shin MK, Park CK, Lee JH, Youn HS, et al. Monoclonal antibodies against Helicobacter pylori cross-react with human tissue. Helicobacter 1997; 2:210-215.
5. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol 2004; 124:91-96.
6. Franceschi F, Christodoulides N, Kroll MH, Genta RM. Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med 2004; 140:766-767.
7. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998; 352:878.
8. Emilia G, Longo G, Luppi M, Gandini G, Morselli M, Ferrara L, et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001; 97:812-814.
9. Kohda K, Kuga T, Kogawa K, Kanisawa Y, Koike K, Kuraiwa G, et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol 2002; 118:584-588.
10. Veneri D, Franchini M, Gottardi M, D'Adda M, Ambrosetti A, Krampera M, et al. Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica 2002; 87:1177-1179.
11. Hino M, Yamane T, Park K, Takubo T, Ohta K, Kitagawa S, et al. Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol 2003; 82:30-32.
12. Ando K, Shimamoto T, Tauchi T, Ito Y, Kuryiama Y, Gotoh A, et al. Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and literature review. Int J Hematol 2003; 77:239-244.
13. Ando T, Tsuzuki T, Mizuno T, Minami M, Ina K, Kusugami K, et al. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura. Helicobacter 2004; 9:443-452.
14. Sato R, Murakami K, Watanabe K, Okimoto T, Miyajima H, Ogata M, et al. Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med 2004; 164:1904-1907.
15. Nomura S, Inami N, Kanazawa S. The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura. Eur J Haematol 2004; 72:304-305.
16. Fujimura K, Kuwana M, Kurata Y, Imamura M, Harada H, Sakamaki H, et al. Is eradication therapy useful as the first line of treatment in Helicobater pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol 2005; 81:162-168.
17. Veneri D, Krampera M, Franchini M. High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: a long-term follow-up study. Platelets 2005; 16:117-119.
18. Inaba T, Mizuno M, Take S, Suwaki K, Honda T, Kawai K, et al. Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest 2005; 35:214-219.
19. Jerque I, Andreu R, Llopis I, De la Rubia J, Gomis F, Senent L, et al. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 2001; 115:1002-1003.
20. Michel M, Cooper N, Jean C, Frissora C, Bussel JB. Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 2004; 103:890-896.
21. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.
22. Malfertheiner P, Megraud F, O'Morain C, Hungin APS, Jones R, Axon A, et al., The European Helicobacter pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection: The Maastricht 2-2000 Consensus Report. Alimentar Pharmacol Ther 2002; 16:167-180.
23. 13C-urea breath test, stool antigen testing, or DNA PCR in human feces in a clinical laboratory setting? Clin Biochem 2004; 37:261-267.
24. Pockros PJ, Duchini A, McMillan R, Nyberg LM, McHutchinson J, Viernes E. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol 2002; 97:2040-2045.
25. Scaradavou A. HIV-related thrombocytopenia. Blood Rev 2002; 16:73-76.
26. McCrae KR, Bussel JB, Mannucci PM, Remuzzi G, Cines DB. Platelets: an update on diagnosis and management of thrombocytopenic disorders. Hematology Am Soc Hematol Educ Program 2001; 1:282-305.
27. Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D. Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 2005; 118:414-419.
28. Emilia G, Luppi M, Zucchini P, Morselli M, Potenza L, Forghieri F, et al. Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. Blood 2007; 110:3833-3841.
29. Gallo N, Zambon CF, Navaglia F, Basso D, Guariso G, Grazia Piva M, et al. Helicobacter pylori infection in children and adults: a single pathogen but a different pathology. Helicobacter 2003; 8:21-28.
30. Russo A, Eboli M, Pizzetti P, Di Felice G, Ravagnani F, Spinelli P, et al. Determinants of Helicobacter pylori seroprevalence among Italian blood donors. Eur J Gastroenterol Hepatol 1999; 11:867-873.
31. Michel M, Khellaf M, Desforges L, Lee K, Schaeffer AS, Godeau B, Bierling P. Autoimmune thrombocytopenic purpura and Helicobacter pylori infection. Arch Int Med 2002; 162:1033-1036.
32. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race and socioeconomic status. Gastroenterology 1991; 100:1495-1501.
33. Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis 2000; 181:1359-1363.
34. Malaty HM, El-Kasabany A, Graham DY, Miller CC, Reddy SG, Srinivasan SR, et al. Age at acquisition of Helicobacter pylori infection: a follow up study from infancy to adulthood. Lancet 2002; 359:931-935.
35. Franchini M, Veneri D. Helicobacter pylori-associated immune thrombocytopenia. Platelets 2006; 17:71-77.
36. Hashino S, Mon A, Suzuki S, Izumiyama M, Kahata K, Yonezumi M, et al. Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori. Int J Hematol 2003; 77:188-194.
37. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005; 106:2244-2251.
38. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120:574-596.
39. Rad R, Gerhard M, Lang R, Schoniger M, Rosch T, Schepp W, et al. The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J Immunol 2002; 168:3033-3041.
40. Suzuki T, Matsushima M, Masui A, Watanabe K, Takagi A, Ogawa Y, et al. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura: a randomized controlled trial. Am J Gastroenterol 2005; 100:1265-1270.
41. Kodama M, Kitadai Y, Ito M, Kai H, Masuda H, Tanaka S, et al. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura. Helicobacter 2007; 12:36-42.